Search results for "progre"

showing 10 items of 1746 documents

Functional correlates of vertical gaze palsy and other ocular motor deficits in PSP: An FDG-PET study

2014

Abstract Objective To determine the functional correlates of vertical gaze palsy and other ocular motor deficits in patients with progressive supranuclear palsy (PSP) using [ 18 F]fluorodeoxyglucose (FDG-)PET. Methods Twenty-six patients with PSP underwent clinical examination of vertical gaze combined with FDG-PET scans to assess regional cerebral glucose metabolism as a marker of neuronal activity. Of these, eighteen PSP patients were also investigated by electrical nystagmography to determine horizontal ocular motor deficits. Statistical parametric mapping analyses were performed to correlate regional neuronal activity with ocular motor functions. Results In categorical comparisons, pati…

AdultMalemedicine.medical_specialtyNystagmographygenetic structuresSmooth pursuitOcular Motility DisordersLingual gyrusOcular Motility DisordersFluorodeoxyglucose F18OphthalmologymedicineHumansPremovement neuronal activityAgedAged 80 and overPalsyOptokinetic reflexMiddle AgedGazeeye diseasesNeurologyPositron-Emission TomographyFemaleSupranuclear Palsy ProgressiveNeurology (clinical)RadiopharmaceuticalsGeriatrics and GerontologyPsychologyNeuroscienceParkinsonism & Related Disorders
researchProduct

Risk for periodontal disease in patients with longstanding rheumatoid arthritis.

1998

Objective. To quantify periodontal disease in rheumatoid arthritis (RA) patients and controls, and to correlate the degree of destruction from periodontal disease and from RA Methods. Fifty RA patients were matched for age, sex, smoking status, and oral hygiene with 101 controls. Correlations between indices of chronic destruction in periodontal disease (gingival attachment loss) and in RA (Larsen radiographic score) were determined. Results. Patients with longstanding active RA (mean ± SD 13 ± 8 years) who were receiving treatment with disease-modifying antirheumatic drugs (n = 46), corticosteroids (n = 38), or nonsteroidal antiinflammatory drugs (n = 43) had a higher rate of gingival blee…

AdultMalemedicine.medical_specialtyOral Hygiene IndexImmunologyGingivaArthritisDentistryOral hygieneGastroenterologyArthritis RheumatoidRheumatologyRisk FactorsInternal medicineImmunopathologyOral and maxillofacial pathologymedicineImmunology and AllergyHumansPharmacology (medical)Risk factorArthrographyAgedAutoimmune diseasebusiness.industryMiddle Agedmedicine.diseaseOral HygieneClinical attachment lossRheumatoid arthritisGingival DiseasesDisease ProgressionFemaleJointsbusinessArthritis and rheumatism
researchProduct

End-of-life situations in cardiology: a qualitative study of physicians' and nurses' experience in a large university hospital.

2018

IF 2.335 (2-year Impact Factor); International audience; Background: rofessional societies call for integration of end-of-life discussions early in the trajectory of heart failure, yet it remains unclear where current practices stand in relation to these recommendations. We sought to describe the perceptions and attitudes of caregivers in cardiology regarding end-of-life situations.Methods: e performed a qualitative study using semi-directive interviews in the cardiology department of a university teaching hospital in France. Physicians, nurses and nurses’ aides working full-time in the department at the time of the study were eligible. Participants were asked to describe how they experienc…

AdultMalemedicine.medical_specialtyPalliative careAttitude of Health Personnellcsh:Special situations and conditionsClinical Decision-MakingPsychological interventionCardiologyContext (language use)Legislation030204 cardiovascular system & hematologyNursing Staff Hospital03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemProfessional-Family RelationsInternal medicinemedicineHumans030212 general & internal medicineQualitative ResearchHeart FailureTerminal Carelcsh:RC952-1245Palliative CareGeneral MedicineProfessional-Patient RelationsMiddle Aged[SDV.ETH] Life Sciences [q-bio]/Ethics[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system[SDV.ETH]Life Sciences [q-bio]/Ethics3. Good healthDistressHospitalistsCardiologyDisease ProgressionProfessional associationFemaleInterdisciplinary CommunicationCardiology Service HospitalFranceThematic analysisPsychologyAdvance DirectivesQualitative researchResearch ArticleEnd-of-lifeBMC palliative care
researchProduct

Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis

1997

Lysosomal cathepsins D (CD), B (CB), and L (CL) serum levels were determined by immunoassays in patients with chronic (CHP) or acute (AP) pancreatitis and in patients with ductal pancreatic carcinoma (DPC) and correlated with some biological and clinical parameters of this tumor. CB serum concentrations significantly higher than those measured in healthy subjects (NS) were observed in CHP, AP, and DPC patients (p < 0.01). However, no significant difference was noted among these groups. Increased CL serum levels were evident only in cancer patients compared to NS, AP, or CHP groups (p < 0.05), while no difference was observed among these groups. Elevated CD serum values were observed i…

AdultMalemedicine.medical_specialtyPancreatic diseaseCA-19-9 AntigenEndocrinology Diabetes and MetabolismCathepsin LLysosomal proteinaseCathepsin DTumor markers.Cathepsin BEndocrinologyPancreatic cancerInternal medicineEndopeptidasesInternal MedicinemedicineCarcinomaAspartic Acid EndopeptidasesHumansAntigens Tumor-Associated CarbohydrateAgedAged 80 and overVHepatologybusiness.industryCarcinoma Ductal BreastCancerPancreatic cancerMiddle Agedmedicine.diseaseCathepsinsPancreatic NeoplasmsCysteine EndopeptidasesEndocrinologymedicine.anatomical_structurePancreatitisTumor progressionAdenocarcinomaPancreatitisFemalePancreasbusinessLysosomes
researchProduct

Colony-Stimulating Factor-1

2015

A noninvasive means to predict the onset and recurrence of lupus nephritis (LN) before overt renal injury is needed to optimize and individualize treatment. Colony-stimulating factor-1 (CSF-1) is expressed by kidney tubules at the onset of LN, increases with disease progression, and spills into the circulation in lupus-prone mice. We tested the hypothesis that amplified expression of CSF-1 detected in the serum or urine correlates with intrarenal CSF-1 expression and histopathology (increased macrophage accumulation, activity indices) and clinical kidney disease activity and predicts the onset and recurrence of nephritis in patients with systemic lupus erythematosus (SLE). We found increase…

AdultMalemedicine.medical_specialtyPathologyAdolescentBiopsyKidney GlomerulusLupus nephritisSeverity of Illness IndexGastroenterologyYoung AdultPredictive Value of TestsInternal medicineBiopsymedicineHumansLongitudinal StudiesAgedRetrospective StudiesKidneymedicine.diagnostic_testbusiness.industryMacrophage Colony-Stimulating FactorReproducibility of ResultsGlomerulonephritisGeneral MedicineMiddle Agedmedicine.diseaseLupus NephritisBasic ResearchKidney Tubulesmedicine.anatomical_structureNephrologyCase-Control StudiesDisease ProgressionFemaleHistopathologybusinessSerositisNephritisBiomarkersKidney diseaseJournal of the American Society of Nephrology
researchProduct

Changing associations between cognitive impairment and imaging in multiple sclerosis as the disease progresses.

2013

The authors explored cross-sectional associations between MRI parameters (lesion metrics, brain volumes, magnetization transfer ratio histograms, and metabolite concentrations) and cognition in 61 patients who experienced clinically-isolated syndromes (CIS) 7 years earlier. IQ decline and poorer overall cognition were associated with T2 white-matter lesions, and slow information-processing with both T2 lesions and gray-matter atrophy. In a previous study of the same cohort, gray-matter atrophy measured shortly after CIS failed to predict development of cognitive impairment years later. Our findings suggest that gray-matter pathology, reflected by atrophy measurements, becomes increasingly i…

AdultMalemedicine.medical_specialtyPathologyIntelligenceStatistics as TopicDiseaseAudiologyNeuropsychological Testsmultiple sclerosisLesionDisability EvaluationExecutive FunctionAtrophyMemorymedicineHumansOptic neuritisAttentionCognitive impairmentbusiness.industryMultiple sclerosisBrainCognitionMiddle AgedVerbal Learningmedicine.diseaseMagnetic Resonance ImagingPsychiatry and Mental healthCross-Sectional StudiesCohortDisease ProgressionFemaleNeurology (clinical)medicine.symptombusinessCognition DisordersFollow-Up Studies
researchProduct

Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome

2003

Background: High serum levels of soluble intercellular adhesion molecule-1(s-ICAM-1/s-CD54) have been associated with adverse clinical features and poor outcome in chronic lymphocytic leukemia, Hodgkin’s disease and non-Hodgkin’s lymphoma, but their value in the different subtypes of non-Hodgkin’s lymphoma has not been well addressed. Patients and methods: Our aim was to study the serum levels of s-ICAM-1 in diffuse large B-cell lymphoma (DLBCL) and to correlate them with clinical characteristics and outcome. We analyzed the serum levels of s-ICAM-1 in a series of 55 patients with DLBCL diagnosed in a single institution. s-ICAM-1 levels were quantified by an immunoenzymatic assay. Median ag…

AdultMalemedicine.medical_specialtyPathologyLymphoma B-CellChronic lymphocytic leukemiaGastroenterologyImmunoenzyme TechniquesInternational Prognostic IndexRisk Factorshemic and lymphatic diseasesInternal medicineAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumormedicineHumansSurvival analysisAgedAged 80 and overL-Lactate DehydrogenaseBeta-2 microglobulinbusiness.industryLymphoma Non-HodgkinLarge-cell lymphomaHematologyMiddle AgedIntercellular Adhesion Molecule-1Prognosismedicine.diseaseSurvival AnalysisLymphomaTreatment OutcomeOncologyB symptomsCase-Control StudiesLymphatic MetastasisDisease ProgressionFemaleLymphoma Large B-Cell Diffusemedicine.symptombusinessDiffuse large B-cell lymphomaAnnals of Oncology
researchProduct

Morphometric assessment of testicular changes in drug-related fatalities.

2000

Testicular sections of 50 deceased drug addicts were examined by light microscopy using morphometric methods and determining the extent of spermatogenesis by application of the Johnsen score count. Twenty cases of violent death served as reference sample. The study was aimed at obtaining data about the degree of germinal gland damage following the duration of the individual drug career, which was correlated to the histologic findings. Progressively reduced maturation of germinal cells, decrease of tubular diameter and height of sperm-producing epithelium were found the longer the individual case history has been. The results clearly indicated a substantial impairment of male fertility in th…

AdultMalemedicine.medical_specialtyPathologyTime FactorsSubstance-Related DisordersBiopsyPhysiologyAutopsySeverity of Illness IndexTesticular DiseasesPathology and Forensic MedicineMale infertilityRisk FactorsSeverity of illnessBiopsymedicineHumansSpermatogenesisInfertility Malemedicine.diagnostic_testSperm Countbusiness.industryMedical jurisprudenceCase-control studyMiddle Agedmedicine.diseaseSubstance Abuse DetectionCase-Control StudiesEtiologyDisease ProgressionAutopsybusinessLawSpermatogenesisForensic science international
researchProduct

Temporal evolution of stress in the year prior to the onset of depressive disorders

1999

Abstract Background . We investigate how the stress levels in a sample of patients with depressive disorders vary in the year prior to the onset of symptoms. Design . Observational study of the case/control type. Fifty patients whose first depressive episode began in the 6 months prior to the interview Method . The LEDS was applied to all the subjects. A calculation was made of the evolution week by week of stress throughout the year prior to the onset. Results . Notable differences were detected in the temporal profile of the stress between the depressive patients and control groups. The differences between them were especially far-reaching in the 26 weeks prior to the onset of the symptom…

AdultMalemedicine.medical_specialtyPediatricsTime FactorsObservationmedicine.disease_causeSeverity of Illness IndexExtinction PsychologicalStress levelLife Change EventsSeverity of illnessStress (linguistics)medicineHumansPsychological stressPsychiatryDepression (differential diagnoses)Depressive DisorderDisease progressionCase-control studyPsychiatry and Mental healthClinical PsychologyCase-Control StudiesDisease ProgressionFemaleObservational studyPsychologyStress PsychologicalJournal of Affective Disorders
researchProduct

A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagoga…

2009

The combination of irinotecan with 5-fluorouracil demonstrates efficacy with tolerable safety in the first-line treatment of metastatic gastroesophageal cancer (mGC). This randomized phase II trial compared for the first time capecitabine with irinotecan or cisplatin in this setting.Patients were randomly assigned to receive 3-week cycles of capecitabine 1000 mg/m(2), twice daily for 14 days, with on day 1 either irinotecan 250 mg/m(2) (XI) or cisplatin 80 mg/m(2) (XP). The primary end point was overall response rate (ORR) and secondary end points included progression-free survival (PFS), overall survival (OS) and safety.Of 118 patients recruited, 112 were eligible for safety analysis and 1…

AdultMalemedicine.medical_specialtyPhases of clinical researchKaplan-Meier EstimateAdenocarcinomaIrinotecanDeoxycytidineGastroenterologyCapecitabineStomach NeoplasmsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProgression-free survivalStomach cancerCapecitabineAgedbusiness.industryCombination chemotherapyHematologyMiddle Agedmedicine.diseaseSurgeryIrinotecanRegimenOncologyFluorouracilCamptothecinFemaleEsophagogastric JunctionFluorouracilCisplatinbusinessmedicine.drugAnnals of Oncology
researchProduct